Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

CARM holding history

Carisma Therapeutics Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CARM overviewAll 13F holders of CARMFull Q4 2025 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of CARM by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−350,324−100.0%Sold outHolders
Q3 2025350,324$96.0K<0.1%00.0%UnchangedHolders
Q2 2025350,324$137.3K<0.1%−1,045,284−74.9%ReducedHolders
Q1 20251,395,608$432.6K<0.1%−23,240−1.6%ReducedHolders
Q4 20241,418,848$594.5K<0.1%−29,399−2.0%ReducedHolders
Q3 20241,448,247$1.42M<0.1%00.0%UnchangedHolders
Q2 20241,448,247$2.20M<0.1%−131,714−8.3%ReducedHolders
Q1 20241,579,961$3.59M<0.1%+11,200+0.7%AddedHolders
Q4 20231,568,761$4.60M<0.1%+8,435+0.5%AddedHolders
Q3 20231,560,326$6.60M<0.1%+50,864+3.4%AddedHolders
Q2 20231,509,462$13.2M<0.1%+943,743+166.8%AddedHolders
Q1 2023565,719$1.75M<0.1%+23,004+4.2%AddedConverted for a 1-for-20 splitHolders
Q4 202210,854,300$6.62M<0.1%+4,2370.0%AddedHolders
Q3 202210,850,063$4.61M<0.1%+107,690+1.0%AddedHolders
Q2 202210,742,373$8.71M<0.1%−1,952,403−15.4%ReducedHolders
Q1 202212,694,776$7.65M<0.1%+328,020+2.7%AddedHolders
Q4 202112,366,756$10.1M<0.1%+2,163,226+21.2%AddedHolders
Q3 202110,203,530$8.09M<0.1%+1,699,548+20.0%AddedHolders
Q2 20218,503,982$39.3M<0.1%+1,308,430+18.2%AddedHolders
Q1 20217,195,552$18.7M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.